NASDAQ:PBYI - Nasdaq - US74587V1070 - Common Stock - Currency: USD
Overall PBYI gets a fundamental rating of 5 out of 10. We evaluated PBYI against 555 industry peers in the Biotechnology industry. While PBYI has a great profitability rating, there are some minor concerns on its financial health. PBYI has a bad growth rate and is valued cheaply. These ratings would make PBYI suitable for value investing!
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 19.4% | ||
ROE | 39.2% | ||
ROIC | 26.87% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 16.01% | ||
PM (TTM) | 16.36% | ||
GM | 72.4% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.11 | ||
Debt/FCF | 1.8 | ||
Altman-Z | -6.24 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.53 | ||
Quick Ratio | 1.43 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 4.45 | ||
Fwd PE | 8.59 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 5.46 | ||
EV/EBITDA | 2.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
3.43
+0.1 (+3%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 4.45 | ||
Fwd PE | 8.59 | ||
P/S | 0.73 | ||
P/FCF | 5.46 | ||
P/OCF | 5.44 | ||
P/B | 1.75 | ||
P/tB | 3.52 | ||
EV/EBITDA | 2.11 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 19.4% | ||
ROE | 39.2% | ||
ROCE | 34.01% | ||
ROIC | 26.87% | ||
ROICexc | 179.97% | ||
ROICexgc | N/A | ||
OM | 16.01% | ||
PM (TTM) | 16.36% | ||
GM | 72.4% | ||
FCFM | 13.39% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.11 | ||
Debt/FCF | 1.8 | ||
Debt/EBITDA | 0.22 | ||
Cap/Depr | 1.02% | ||
Cap/Sales | 0.05% | ||
Interest Coverage | 3.81 | ||
Cash Conversion | 64.28% | ||
Profit Quality | 81.87% | ||
Current Ratio | 1.53 | ||
Quick Ratio | 1.43 | ||
Altman-Z | -6.24 |